Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age...
Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
To analyze the risk factors associated with emerging intraocular inflammation (IOI) after intravitreal brolucizumab injection (IVBr) to treat age-related macular degeneration (AMD).
This study included 93 eyes of 90 patients. The incidence of emerging IOI was analyzed. The patients were classified into IOI or non-IOI groups, and background clini...
Alternative Titles
Full title
Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2607269780
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2607269780
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0259879
